Miao, Lei
Cao, Ying
Zuo, LiJing
Zhang, HongTu
Guo, ChangYuan
Yang, ZhaoYang
Shi, Zhuo
Jiang, JiuMing
Wang, ShuLian
Li, YeXiong
Wang, YanMei
Xie, LiZhi
Li, Meng
Lu, NingNing http://orcid.org/0000-0003-4636-6035
Funding for this research was provided by:
Cancer Hospital & Institute (LC2020A15)
Article History
Received: 23 July 2022
Revised: 1 November 2022
Accepted: 5 December 2022
First Online: 29 December 2022
Declarations
:
: The scientific guarantor of this publication is NingNing Lu (MD, Department of Radiation Oncology) and Meng Li (MD, Department of Radiology), National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
: Authors YanMei Wang and LiZhi Xie are employees of GE Healthcare. The remaining authors declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: YanMei Wang kindly provided statistical advice for this manuscript.
: Informed consent was obtained. All methods were carried out in accordance with relevant guidelines and regulations.
: The Ethical Committee at the Cancer Hospital, Chinese Academy of Medical Sciences, approved this prospective study (NCT05167994/ChiCTR2000033377, NCT05235100).
: • Prospective• Diagnostic or prognostic study• Performed at one institution